Clinical trials
Active, not recruiting Phase 2 trials in Peru
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2010 | 1 |
| 2018 | 1 |
| 2022 | 2 |
| 2023 | 4 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 3 |
| Alumis Inc | 1 |
| AstraZeneca | 1 |
| Eagle Pharmaceuticals, Inc. | 1 |
| Genentech, Inc. | 1 |
| Hoffmann-La Roche | 1 |
| Immunovant Sciences GmbH | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
| Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Autoimmune Diseases | 1 |
| Breast Neoplasms | 1 |
| Connective Tissue Diseases | 1 |
| Hypertension, Pulmonary | 1 |
| Immune System Diseases | 1 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 |
| Lung Diseases, Interstitial | 1 |
| Lupus Erythematosus, Systemic | 1 |
| Lymphoma, Follicular | 1 |
| Lymphoma, Mantle-Cell | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.